Inco (IN.) Quote

It can move violently with the right sugar and spice news, would be nice if their Ai technology really works

Can't wait to see what the 2024 - 2025 results are. Will Jake and his scam make the list?


https://www.sec.gov/newsroom/press-releases/2023-234

Best thing for investors, and our financial system, is for the judge to deny the appeal. There is no precedence and setting one now is important. The weasel scab is just looking for more money to fight other crypto exchange cases.

I wonder if the receiver will pay the 3 stooges 6 figure bonuses?

The caddy probably cost 20 million

Good morning CLNVers

FOXO Way undervalued at these levels,will bounce with some positive updates

MYNA 1.63 x 1.70 where we go ???

May have to buy more shares today. We continue to build momentum as we enter the 4th quarter with a great ceo.

MYNA 1.64 X1.70 up 30%

Why don’t you prove that troll baby. lol

Also remember a paleo diet and those girly boobs may go away

Start you engines100m market cap valuation Next resistance will be tested

I’m not the one who obsessively defended a Medicare man that commits fraud and plays dress up but that’s just me!

Putting together a large launch pad evidently.

In UMAC-LUXH-LGHL-MLGO

Says with certainty VuMe SuperApp will launch this year.

$$$ Today is the Day $$$$

$$$$ $frx $$$$

I'm afraid Nuts he has a valid point 😆

The company is worth $20billion right now in a normal market that was run by an honest exchange . Price is over $30 billion with only a MHRA approval and $75 billion with FDA approval.



good lord. You cant be serious. NWBO has zero revenue that does not change in the mo

MLGO: lol That candle is about 50% of the final price.

Think mergers and acquisitions

https://pitchbook.com/profiles/company/437230-27#overview

Wow! Denial is deep here. Easy to keep it going, though, when choosing to insert alternative realities. I'd suggest attempting to go beyond focusing on just the Risk Factors section of the filings. Maybe allow oneself to view the MANY excerpts I've provided straight from these legal filings over the

$AIMD #Nasdaq Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome https://finance.yahoo.com/news/ainos-spotlighted-water-tower-research-145500248.html

Power2 the P1ayers Huzzah!🟩24/7 interest here🟩 🟩

Further evidence that ANIP is preparing to be bought out. On July 29. 2024, Novitium Pharma (ANIP subsidiary) gained NDA approval for Tezruly (oral solution of terazosin) and was authorized to market it August 1, 2024. ANIP never announced the approval or launched the drug. According to the Orange